When news happens, text LT and your photos and videos to 80360. Or contact us by email or phone.
Blackburn mum fights on after meningitis tragedy
Toni Burford (front) is joined by (from left) Steve Dayman, Jodie Marsh and Kirk Catterall as they collect signatures outside Blackburn Town Hall.
A MUM who was left devastated when her 17-year-old daughter suddenly died from meningitis has joined a campaign for routine vaccinations against the disease.
Dannielle Catterall was an active and healthy teenager until March 4, 2009, when she returned home from Blackburn College suffering from a migraine.
Mum Toni Burford, 38, became more concerned when she vomited and started to become unresponsive, and dialled 999.
When paramedics arrived they detected a small red mark on her stomach and rushed her to hospital, by which time the rash had covered her body. Just hours after being diagnosed with meningitis B,she was dead.
Toni and Dannielle’s dad Kirk, of Hamilton Street, Mill Hill, have been struggling to come to terms with what happened for the last four years, and are now involved in a campaign with Meningitis UK. Toni joined the charity’s ‘Beat-it-Now’ trailer outside Blackburn Town Hall on Friday, to call for the newly-licensed meningitis B jab to be included in the list of vaccines routinely administered to children.
The mum-of-two said: “The whole family is affected by such an awful illness that can take your loved one so easily.
“This will not bring our Dannielle back but will help to stop families going through this heartache, and help future generations.
“Younger siblings can be affected by what I would call separation anxiety – how do you explain one day you see your sister and the next day they are gone forever?”
She has also been busy organising sponsored ‘Toddle Waddles’ for nursery children, to raise funds for further meningitis research.
Earlier this year, the health officials who advise the NHS decided a newly-licensed meningitis B vaccine called Bexsero would not be added to the routine childhood vaccination schedule.
They said: “On the basis of the available evidence, routine infant or toddler immunisation using Bex- sero is highly unlikely to be cost-effective at any vaccine price.”
Comments are closed on this article.